What companies are VIRS's competitors?

Pacer BioThreat Strategy ETF (VIRS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does VIRS compare to its peers?

The peer comparison table on this page shows Pacer BioThreat Strategy ETF (VIRS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does VIRS operate in?

Pacer BioThreat Strategy ETF (VIRS) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

VIRS (Pacer BioThreat Strategy ETF) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

VIRS

Pacer BioThreat Strategy ETF

CBOE·Asset Management · Financial Services

$40.03$0.01+0.03%

Market cap$4.00M·Market closed·Oct 10 5:16 PM UTC

Frequently Asked Questions About VIRS

What companies are VIRS's competitors?: Pacer BioThreat Strategy ETF (VIRS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VIRS compare to its peers?: The peer comparison table on this page shows Pacer BioThreat Strategy ETF (VIRS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VIRS operate in?: Pacer BioThreat Strategy ETF (VIRS) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

VIRS (Pacer BioThreat Strategy ETF) is no longer actively trading.

VIRS

Pacer BioThreat Strategy ETF

CBOE·Asset Management · Financial Services

$40.03$0.01+0.03%

Market cap$4.00M·Market closed·Oct 10 5:16 PM UTC

Peers


MTVR	L&G Metaverse ESG Exclusions UCITS ETF	$17.53	$4.4M
IVEG	iShares Emergent Food and AgTech Multisector ETF	$21.65	$4.3M
URAX	Defiance Daily Target 2X Long Uranium ETF	$7.94	$4.1M
DSOC	Innovator Double Stacker ETF – October	$32.33	$4.0M
INNO	Harbor Disruptive Innovation ETF	$17.72	$3.9M
BNE	Blue Horizon BNE ETF	$22.49	$3.9M
NSPY	NightShares 500 ETF	$29.56	$3.8M
QQC	Simplify Nasdaq 100 plus convexity ETF	$24.46	$3.7M
DCAP	Unity Wealth Partners Dynamic Capital Appreciation & Options ETF	$21.11	$3.6M
RORO	ATAC US Rotation ETF	$16.35	$3.6M

Frequently Asked Questions About VIRS

What companies are VIRS's competitors?: Pacer BioThreat Strategy ETF (VIRS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VIRS compare to its peers?: The peer comparison table on this page shows Pacer BioThreat Strategy ETF (VIRS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VIRS operate in?: Pacer BioThreat Strategy ETF (VIRS) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.